Wednesday, February 21, 2018
Biopharmaceuticals Cancer Tumor US Patent Third

Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) Gains 17.86% After Receiving Third Cancer Combination US Patent

Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT) is a clinical-stage biotechnology company that develops treatments for tumors, cancers, and other ailments. Shares of the biotechnology company...
Hospital Senior Care Facility LOI

Toron, Inc. (OTC Pink: TRON) Jumps 43.90% After Releasing Corporate Update

Toron, Inc. (OTC Pink: TRON), through its subsidiary iMedScan Corp., offers electronic data software for healthcare insurance verification. Shares of the healthcare technology developer...
Oncology Advisory Board Clinical Trials Meeting

PharmaCyte Biotech, Inc. (OTCQB: PMCB) Gains 15.37% After Meeting With Oncology Advisory Board

PharmaCyte Biotech, Inc. (OTCQB: PMCB) is engaged within the research, development, and commercialization of medical technologies that can treat cancer and diabetes. Shares of...
Healthcare Communications Asset Purchase Agreement

iCoreConnect, Inc. (OTC Pink: VMCI) Rallies 32.35% After Entering Into Asset Purchase Agreement With...

iCoreConnect, Inc. (OTC Pink: VMCI) operates as a healthcare technology and communication provider. Shares of the medical company are rallying 32.35%, through early trading...
Medical Device Scanner Cervical Cancer Development Turkey

Guided Therapeutics, Inc. (OTCQB: GTHP) Jumps 56.09% After Signing Preliminary License Agreement With Turkish...

Guided Therapeutics, Inc. (OTCQB: GTHP) operates as a medical device manufacturer of early disease detection. Shares of the medical device manufacturer are climbing 56.09%,...
Propanc Biopharma Cancer Human Trials Begin 2018

Propanc Biopharma, Inc. (OTCQB: PPCB) Jumps 43.33% After Advancing To GMP Manufacture of PRP...

Propanc Biopharma, Inc. (OTCQB: PPCB) is engaged within the research, development, and commercialization of treatments for pancreatic, ovarian, and colorectal cancers. Shares of the...
Biotech Research Favorable Results Published Journal of Oncology

Delcath Systems, Inc. (OTCQB: DCTH) Surges 88.85% After Receiving Favorable Results From Multi-Center Analysis...

Delcath Systems, Inc. (OTCQB: DCTH) operates within the research, development, and commercialization of oncology treatments. Shares of the oncology treatment developer are surging 88.85%,...

Cancers Last Stand – GR-MD-02 Nearly Doubles Response Rate when added to Keytruda

Historic Phase 1a Efficacy Data Clearly Defined Approvable Pathway for GR-MD-02 Bidding War – Merck Do or Die Situation Platform Technology Case Increases...
Oncology Treatment Provider Clinical Trials Appointment

Rich Pharmaceuticals, Inc. (OTC Pink: RCHA) Jumps 40% After Retaining Contact Research Organization To...

Rich Pharmaceuticals, Inc. (OTC Pink: RCHA) is a biopharmaceutical company that is engaged within the research, development, and commercialization of oncology treatments. Shares of...
Medical Device Reformulation Proprietary Forumlas

Omni Health, Inc. (OTC Pink: OMHE) Climbs 20.50% After Announcing Development of New Drug

Omni Health, Inc. (OTC Pink: OMHE) operates as a vertically integrated healthcare company that develops pharmaceuticals, anti-aging products, and other bioengineering. Shares of the...

STAY CONNECTED

145,386FansLike
1,230FollowersFollow
1,283FollowersFollow
180SubscribersSubscribe

MOST POPULAR